Physicians, Innovations, Science for Children Fund Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2019
NCT03846362
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Physicians, Innovations, Science for Children Fund

Active Ingredients

Drugs in Phase 3 Trials (1)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1